What Does Nanobiotix Do?

Total employees146
HeadquartersParis
Founded2003

Nanobiotix is a late-clinical stage biotechnology company focused on developing pioneering, physics-based solutions to bring new possibilities to cancer patients. The company's first-in-class lead product candidate, NBTXR3, is a radioenhancer composed of hafnium oxide nanoparticles. It is designed for direct injection into tumors and activation by radiotherapy, aiming to enhance the local efficacy of radiation by physically increasing the energy dose deposit within the tumor without increasing toxicity to surrounding healthy tissues. NBTXR3 is being evaluated in multiple solid tumor indications as a monotherapy and in combination with other anti-cancer treatments, including immune checkpoint inhibitors.

Where Is Nanobiotix's Headquarters?

HQ Function

The Paris headquarters serves as the primary center for strategic leadership, global operational management, core research and development activities, and corporate functions.

Notable Features:

Features modern office spaces and advanced laboratory facilities tailored for nanomedicine research, development, and analytical activities.

Work Culture:

Characterized by a strong emphasis on innovation, scientific rigor, and collaboration. The culture fosters a patient-centric approach, with employees driven by the mission to transform cancer treatment.

HQ Significance:

The headquarters is central to Nanobiotix's global strategy, facilitating European operations, R&D advancements, and engagement with the European biotechnology ecosystem. Its location offers access to leading research institutions and talent.

Values Reflected in HQ: The headquarters embodies Nanobiotix's core values of innovation, scientific excellence, patient focus, and a commitment to advancing global health through breakthrough technologies.

Location:

Nanobiotix maintains a global operational scope, with its main headquarters in Paris, France, and a U.S. hub in Cambridge, Massachusetts. The company's clinical trial programs for NBTXR3 are international, involving sites and investigators across North America, Europe, and the Asia-Pacific region. Through strategic collaborations and a focus on global regulatory pathways, Nanobiotix aims to make its innovative cancer treatments available to patients worldwide.

Street Address:

60 Rue de Wattignies

City:

Paris

State/Province:

Île-de-France

Country:

France

Where Else Does Nanobiotix Operate Around the World?

Cambridge, Massachusetts/USA

Address: One Broadway, 14th Floor, Cambridge, MA 02142

Establishes a strategic presence in a major global biotechnology hub, providing access to U.S. capital markets, specialized talent, academic collaborations, and key opinion leaders in oncology. Supports the expansion of NBTXR3 development in the U.S.

Buying Intent Signals for Nanobiotix

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Nanobiotix? Meet the Executive Team

As of April 2025, Nanobiotix' leadership includes:

Laurent Levy - Co-founder, Chairman of the Executive Board
Gary Phillips - Chief Executive Officer, Nanobiotix Corp. (US Operations)
Bart van Rhijn - Chief Financial Officer
Louis Kayitalire, M.D. - Chief Development Officer
Leonard W.W. Thomas, Ph.D. - Chief Scientific Officer
Anne-Juliette Hermant - Chief People & Sustainability Officer

Who's Investing in Nanobiotix?

Nanobiotix has been backed by several prominent investors over the years, including:

Publicly Traded (Euronext Paris: NANO, NASDAQ: NBTX)
Janus Henderson Investors
Invus Group
Bpifrance Participations
Heights Capital Management

What Leadership Changes Has Nanobiotix Seen Recently?

Hire2
Exits1

Over the past 12-18 months, Nanobiotix has made key appointments to strengthen its executive leadership, notably a new Chief Financial Officer and a new Chief Development Officer, to drive its late-stage clinical programs and strategic growth initiatives.

Departures

Philippe Mauberna, Philippe Mauberna departed from his position as Chief Financial Officer.

New Appointments:

Bart van Rhijn, Bart van Rhijn appointed as new Chief Financial Officer, succeeding the previous CFO.
Louis Kayitalire, Dr. Louis Kayitalire appointed as new Chief Development Officer to oversee development pipeline.

What Technology (Tech Stack) Is Used byNanobiotix?

Discover the tools Nanobiotix uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Nanobiotix Email Formats and Examples

Nanobiotix likely employs standard corporate email address formats. The most common patterns observed for companies of its structure and origin are [first_initial][last_name]@nanobiotix.com or [first_name].[last_name]@nanobiotix.com.

[first_initial][last]@nanobiotix.com (e.g., jdoe@nanobiotix.com)

Format

llevy@nanobiotix.com

Example

90%

Success rate

What's the Latest News About Nanobiotix?

GlobeNewswireMay 23, 2024

NANOBIOTIX Announces Presentation of Updated Results from Expansion Part of Phase 1 Study Evaluating NBTXR3 at ASCO 2024

Nanobiotix announced that updated results from its Phase 1 study (Study 1100) evaluating NBTXR3 activated by radiation therapy in patients with advanced solid tumors will be presented at the 2024 ASCO Annual Meeting. The presentation will cover safety and efficacy data in patient cohorts with lung, liver, and other metastases....more

GlobeNewswireMay 7, 2024

NANOBIOTIX Reports First Quarter 2024 Operational Progress and Financial Results

Nanobiotix provided an update on its Q1 2024 operational achievements and financial standing. Key highlights included progress in the pivotal Phase 3 NANORAY-312 trial for NBTXR3 in head and neck cancer, ongoing execution of its collaboration with Janssen, and cash position to support planned activities....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Nanobiotix, are just a search away.